Denton, CP;
Khanna, D;
(2021)
Rational repurposing of tocilizumab for treatment of lung fibrosis in systemic sclerosis.
Lancet Rheumatology
, 3
(5)
E321-E323.
10.1016/S2665-9913(21)00111-9.
Preview |
Text
Lancet Rheum comment-2021-CD-DK final-for UCL upload.pdf - Accepted Version Download (132kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Rational repurposing of tocilizumab for treatment of lung fibrosis in systemic sclerosis |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S2665-9913(21)00111-9 |
| Publisher version: | https://doi.org/10.1016/S2665-9913(21)00111-9 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10134068 |
Downloads since deposit
119Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
